Neuroendocrine Tumor G1 — Trials

Neuroendocrine Tumor G1 — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–23 of 23 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04197310	Cabozantinib and Nivolumab for Carcinoid Tumors	completed	Phase 2	19	Dana-Farber Cancer InstituteOTHER	1	Jan 31, 2025	clinicaltrials
NCT02893930	Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery	completed	Phase 2	13	National Cancer Institute (NCI)NIH	1	Oct 17, 2023	clinicaltrials